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Regulation of HSV Transcription 
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Department of Molecular Biology and Biochemistry, University of California at Irvine, Irvine, California, U.S.A. 
Herpes simplex virus (HSV) transcripts share many 
features with both cellular mRNA and the mRNAs ex­
pressed by other nuclear-replicating DNA viruses: they 
are capped, polyadenylated, and generally have an ap­
proximately 150 base leader hetween the cap and trans­
lation initiation codon. Further, certain sequence fea­
tures around individual transcription units are shared: 
HSV promoters contain TAT A and often CATC boxes, 
and the sequence signal indicating a polyadenylation 
site (AAT AAAA) is standard. 
In sIrite of these similarities, there is one very distinct 
difference between the structure of HSV transcription 
units and those of other nuclear replicating DNA vi­
ruses. Each HSV transcript appears to be controlled by 
its own promoter and encodes a specific polypeptide. 
Further, the high degree of splicing seen with most 
eukaryotic and viral mRNAs is not seen in HSV. Cer­
tainly, HSV and other herpesviruses do express some 
spliced transcripts, but these are in the minority (with 
HSV at least). Thus a whole hierarchy of potential con­
trol points utilized in eukaryotic gene expression is miss­
ing or rarely utilized in HSV. Despite this, the high 
density of gene packaging and relatively complex ar­
rangement of partially overlapping transcripts is seen 
in HSV transcription as it is in other, smaller DNA 
viruses. 
Judging by distinct members, if nothing else, the herpesvi­
ruses must be considered a very successful group of nuclear­
replicating DNA viruses of vertebrates. Members infecting 
humans include herpes simplex types 1 and 2 (HSV -1 and 
HSV-2), herpes (varicella) zoster (VZV), cytomegalovirus 
(HCMV), and Epstein-Barr virus (EBV). Members of the her­
pesvirus group share general morphologic similarities, large 
genome size, and certain complex features of the physical 
arrangement of their genomes. Many of these features have 
been reviewed in detail elsewhere, notably by Spear and Roiz­
man [1]. 
It is notable that all members of the herpesvirus group have 
complex biological interactions with their hosts. They have the 
ability to establish latent infections. Here the virus is refractory 
to host defense, but yet periodically reerupts. Natural infection 
by certain herpesviruses appears to lead to formation of specific 
neoplasias. Further, specific genetic elements of all herpesvi-
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ruses rigorously tested to date can be shown to induce morpho­
logic transformation in indicator cells. 
Many features of the control of gene expression during the 
replication cycle of the herpes viruses appear to be shared by 
most or all members of the group. Herpes simplex virus (espe­
cially HS V -1) is the most extensively characterized member of 
the group; studies on this virus provide a model for the herpes­
viruses in general. These features have been reviewed [1], and 
aspects of control of transcription of HSV genes were exten­
sively covered by me in two recent reviews [2,3]. 
The replication cycle of HSV demonstrates that the expres­
sion of specific classes of viral genes is temporally controlled. 
Gene expression, as examined by the appearance of either 
specific proteins or the transcripts encoding them, can be 
divided into three general phases. Transcripts of the first 
(immediate-early, or alpha) phase are expressed in the absence 
of de novo protein synthesis in the host. At least one immediate­
early gene (that encoding ICP4) appears to be a major control 
factor in subsequent viral gene expression. Following the ap­
pearance of the immediate-early genes, genes encoding enzymes 
involved in viral DNA replication and certain alterations in the 
cell surface are expressed. These early, or beta, genes are 
expressed as abundant transcripts in the absence or blockage 
of viral DNA synthesis, and their transcription continues at 
high rates following the onset of viral DNA replication. Struc­
tural proteins of the virion and many other proteins, most of 
which have, as yet, unknown function, are expressed as late 
(gamma) transcripts. Late transcripts can be divided into two 
general classes depending on whether they can be detected in 
the absence of viral DNA synthesis. Both require viral DNA 
synthesis to attain their maximum rate of transcription or, at 
least, maximum abundance on polyribosomes. 
This review outlines the general methods used in my labo­
ratory for the precise characterization of HSV transcripts and 
the information they encode. It is shown that despite a complex 
transcription map, each viral transcript encodes a specific 
polypeptide. Thus high-resolution transcription mapping leads 
to a high-resolution genetic map of the virus. Further, the very 
large number of individually acting promoters on the HSV 
genome provides an excellent source of data for comparative 
sequence analysis of one type of eukaryotic promoter. Each 
promoter may also provide conveniently "engineerable" units 
for gene modification studies and for an experimental exami­
nation of the precise factors involved with the temporal control 
of HSV transcription. 
MATERIALS AND METHODS 
Procedures for handling specific regions of the HSV -1 genome as 
recombinant DNA fragments in pBR322 grown in LE:392 were de­
scribed by Anderson et al [4] and Costa et al [5]. Recently, we began 
to use single-stranded DNA clones grown in bacteriophage M 13. 
Procedures for isolation and characterization of specific HSV-1 
transcripts were outlined in several recent reviews from this laboratory. 
Many variations of these methods are used by other laboratories with 
similar results. 
Isolated mRNA can be translated in vitro using commercial rabbit 
reticulocyte lysate systems [4]. We have used specific antibodies (po­
lyclonal and monoclonal) to identify in vitro translation products with 
particular viral proteins. 
We have used RNA (Northern) blots to determine the specific 
number and sizes of HSV transcripts homologous to any given region 
of the genome. We recently described the use of a method for doing 
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RNA blots in situ by using vacuum-dried agarose strips as the sup­
porting medium [6]; such a procedure has the advantage of speed and 
excellent size resolution. 
Radioactive DNA probes are prepared by nick-translation of cloned 
DNA fragments. Sizes of probes as small as 200-300 bases have been 
used t.o precisely locate the position of specific transcripts [7,8]. Re­
cently, the use of single-stranded DNA probes has allowed us to 
determine t.he direction of transcription and high-resolution map lo­
cation (approximately 100 bases) of mRNAs prior to Sl nuclease and 
exonuclease VII digestion of hybrids for precise location of transcripts 
(ca. 25-50 base resolution). Northern blots using RNA from infected 
cells in which viral DNA replication has been blocked allows the 
assignment of the temporal class of a given transcript (i.e., early or late 
[9]). 
Procedures for S1 nuclease mapping of HSV -1 transcripts, the use 
of specific end-labeled DNA probes, and the use of exonuclease VII 
digestion of RNA:DNA hybrids to specifically locate given transcripts 
are described in a number of papers from this group (reviewed in 
[2,3]). 
Nucleotide sequence analysis was performed by the method of 
Maxam and Gilbert [10]. Procedures for the precise location of the 5' 
and 3' ends of specific mRNAs (ca. 10 base resolution) were outlined 
by Frink and coworkers [7,11J. 
RESULTS 
High-Resolution Transcription Map of HSV-l 
To date, we have carried out high-resolution transcription 
mapping in the 23-kilobase (kb) region between 0.15 and 0.3 
map units and in the 52-kb region between 0.4 and 0.75 map 
units on the HSV -1 genome. These data, along with data taken 
from several other laboratories, yield the map shown in Fig 1. 
Although many overlapping mRNA "families" are seen, most 
show no evidence of splices. There are, however, exceptions. 
The transcription unit encoding glycoprotein C (gC) (0.63-
0.65) has several low-abundance spliced members [7,12). Sev­
eral other mRNAs appear to have short discontinuities near 
their 5' ends. These are indicated by brackets at those 5' ends 
in Fig 1. To date, however, only one mRNA, a 2.8-kb one 
mapping between 0.185 and 0.225 map units, appears to have 
a large intron. Here we have determined it to be of the order of 
4 kb (Costa, Draper, and Wagner, unpublished). We expect 
other exceptions to occur, but as yet we have not found a region 
of the genome where transcripts are as extensively spliced as 
has been seen in some other viral systems. 
Most HSV-l mRNAs mapped do not show significant com­
plementary overlaps with others, but there are exceptions. 
There is a minor 2.7-kb mRNA mapping in HindIII fragment 
L (0.592-0.647) that has a complementary overlap with a major 
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beta mRNA, as well as with the mRNA encoding gC [12). We 
carefully analyzed one group of mRNAs in EcoRI fragment I 
(0.633-0.721) whose 5' ends showed complementary overlap 
and here we found that potential protein coding frames did not 
overlap [6). Other individual cases will require full characteri­
zation by sequence analysis, etc. 
Nuclear Forms of HSV mRNA 
The relatively low frequency of HSV splicing and the fact 
that transcriptional control sequences map contiguously to 
structural genes (see below) both lead to the prediction t.hat 
HSV nuclear mRNA precursors will generally be close to the 
size of the mature product. However, it has long been observed 
that HSV RNA species with nominal sizes greater that 10 kb 
can be isolated from the nucleus (reviewed in [3)). In the case 
of very large nuclear RNA detected under conditions where 
only immediate-early mRNAs were being synthesized, we found 
this RNA hybridized to essentially the same restriction frag­
ments as the alpha mRNAs seen in the cytoplasm. This sug­
gested that much of the apparently large RNA was a result of 
trapping of HSV RNA in large nuclear species. 
We carried out some experiments to examine the properties 
of high-molecular-weight HSV nuclear RNA in general (Frink 
and Wagner, unpublished) . We examined the size distribution 
of nuclear RNA via Northern blot and Sl nuclease analysis. 
The mRNAs encoded by HindIII fragment K (0.527-0.592) 
were used as a standard. At both early and late times after 
infection, RNA transfer (Northern blots) showed that the 
poly(A+) nuclear RNA contained mRNA species identical to 
polyribosomal poly(A) mRNA (see Fig 2, tracks 1-4). The 
picture with total nuclear RNA was complicated by the fact 
that late (but not early) after infection there was considerable 
heterodispersedly migrating RNA of large size (not shown). SI 
nuclease analysis of hybrids between 32P-Iabeled HindIII frag­
ment K DNA and poly(A) nuclear and total nuclear RNA, 
however, showed only the four major species identified with 
polyribosomal (A+) mRNA: 6.0, 4.3, 3.7, and 1.7 kb (Fig 2, 
tracks 6 and 7). Similar conclusions were obtained with mRNA 
from BamHI fragment I (0.60-0.64). Thus we concluded that 
no specific RNA species other than those seen on polyribosomes 
are generally present in readily detectable amounts in the 
nucleus. 
In a second set of experiments, we asked if any members of 
the overlapping mRNAs of HindIII fragment K were kinetic 
precursors to others. We used very short pulses with 'l2p, and 
nuclear poly(A) mRNA was isolated using preparative hybrid-
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FIG 1. High-resolution map of specific HSV -1 mRNAs. The times of appearance of mRNAs are shown at the top along with the size of in 
vitro polypeptides translated from them where known. The direction of transcription is indicated. Position of the transcripts encoded in brackets 
is based on high-resolution Northern blot analysis (ca. 100. base resolution) and only partial Sl nuclease data. Therefore, the exact locations 
should be regarded as tentative. In addition to data from our laborat.ory, we have interpreted data from other laborat.ories for the mRNAs 
indicated wit.h an asterisk ( * ) as described [3J. The transcripts between 0..3 and 0.4 were mapped by L Holland, R Sandri-Goldin, A Goldin, J 
Glorioso, and M Levine (submit.ted for publicat.ion). 
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FIG 2. Nuclear forms of H8V RNA encoded by HindIII fragment K 
(0.527-0.592) are of the same general size as seen on polyribosomes. 
General methods for RNA transfer (Northern blots) and 81 nuclease 
mapping are discussed in Materials and Methods. 
izations. This material was then subjected to size-fractionation. 
At the shortest pulses (ca. 5 min), we found that the proportion 
of 7-, 5.2-, and 1.9-kb mRNAs isolable using a specific HSV-1 
DNA fragment were the same as for longer pulses. We con­
cluded that no readily detectable precursor-product relation­
ship existed between these mRNAs. 
HSV Transcripts Encode Identifiable Viral Proteins 
The transcription map in Fig 1 will serve as a high-resolution 
genetic map for HSV only if individual transcripts can be shown 
to encode specific viral proteins. Such has been done for a 
number of transcripts by workers in my laboratory and in other 
laboratories (reviewed in [2,3]). As an example, consider the 
identification of the 6-kb late mRNA mapping between 0.25-
0.29 as the transcript encoding the major HSV -1 capsid protein 
(VP5). We were able to tentatively make this assignment on 
the basis of a number of indirect criteria, including size of the 
in vitro translation product and correlation with intertypic 
recombinant mapping data [5]. We recently made an absolute 
assignment by using a specific antiserum against VP5 to iden­
tify the in vitro translation product of the 6-kb mRNA [13]. A 
typical result is shown in Fig 3. A final confirmation was 
performed by comparing tryptic peptides of authentic and in 
vitro translated VP5. A number of mRNA species have been 
characterized by workers in this and other laboratories. A 
complete listing of these is available [3]. 
The relative ease of making such assignments leads us to 
some confidence that the information encoded in the majority 
of transcripts seen in HSV -1 infection have a readily definable 
function. This will be of great use in studies on gene-controlling 
factors involved in HSV pathogenesis. For example, we recently 
collaborated with another group to determine that one or 
several HSV -1 genes involved in neurovirulence in mice can be 
mapped to a specific region of the genome [14]. The patterns 
of HSV transcription we have characterized suggest that such 
functions will be assignable to specific proteins and the tran­
scripts encoding them will be identifiable. This leads to obvious 
approaches for the study of the molecular mechanisms of HSV 
pathogenesis. 
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Sequence A nalysis of HSV Transcription Units 
The complete nucleotide sequence of the transcription units 
around the gene encoding HSV-1 gC has been published [7]. A 
schematic representation of some important features of these 
data is shown in Fig 4 and serves as a useful model for other 
HSV transcription units. I have briefly outlined some of the 
features of such units in the following sections. 
Promoters. The data available concerning properties of dif­
ferent HSV promoters has been extensively reviewed [3]. The 
best model for the promoters in general comes from the work 
of McKnight [15] with the HSV-1 thymidine kinase (tk) pro­
moter. Herpes simplex virus promoters must be responsive to 
both cellular factors (RNA polymerase II, etc.) and viral control 
factors that regulate both the time of expression of given 
temporal classes of viral genes and, presumably, the amount of 
transcription taking place. On the basis of partial data from a 
number of other laboratories (reviewed in [3]), it is reasonable 
to suggest that many, if not all, of the control sequences 
involved in early and late HSV promoter function will be found 
in the 250 or so bases directly upstream from the mRNA cap 
site. Actually, the size of such promoters may be only 120 bases 
or so, based on the DNA modification studies of McKnight 
referred to earlier. 
Early HSV genes are generally expressible at low levels in 
uninfected cells. We showed that, generally, early (beta) HSV-
1 promoters are properly recognized by RNA polymerase com­
plexes from uninfected cells (Manley systems). In contrast, we 
have found that the promoter for the late 6-kb mRNA encoding 
VP5 was not efficiently recognized [11]. Recently, we have 
prepared Manley-type extracts from HSV -1 infected cells taken 
8 hours after infection. Such systems generally show increased 
activity as judged by total incorporation of label into product. 
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FIG 3. Immune precipitation of the major H8V -1 capsid protein 
(VP5) by specific antisera. The 155,000 dalton translation product of 
the 6-kb mRNA was reacted with antiserum (NCl) as discussed [8]. 
Precipitation of total in vitro translation product of HSV poly(A) 
mRNA with immune rabbit serum (72-1) is shown for comparison. 
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Further, our data are consistent with the system's being able 
to initiate transcription near the cap site for the 6-kb mRNA 
(Draper and Wagner, unpublished). Unfortunately, the system 
from infected cells initiates at a number of sites that do not 
correspond to recognizable late mRNA cap sites; therefore, 
specificity is suspect. 
R. Costa, in my laboratory, has generated a transcription 
expression marker by modification of pBR322. This marker 
contains a restriction site into which the VP-5 promoter has 
been placed. We have found that transfection of this marker 
into HeLa cells, followed by superinfection with HSV, leads to 
specific induction of transcription. Such a marker will hopefully 
be of value in assessing which viral factors are responsible for 
efficient transcription from late promoters. 
We have carried out preliminary experiments with protein­
transfer blots to examine the specificity of ds-DNA binding to 
infected cell nuclear extracts (Steinhart and Wagner, unpub­
lished). High-salt (1. 7 M) extracts of infected cell nuclei contain 
several protein species not seen in uninfected cell extracts that 
bind to DNA probes made by nick-translating BamHI fragment 
F' , the fragment containing the promoter region for the 6-kb 
late mRNA. Competition experiments with pBR322 DNA or 
HSV Sail fragment N' DNA (a region in HindIII fragment L 
that does not contain any recognizable promoter) suggest that 
the binding is sequence-specific (Fig 5). Such preliminary data 
give hope that protein factors involved in the regulation of 
specific HSV promoter function may be available for detailed 
experimental investigation. 
Comparative sequence analysis of a number of early and late 
HSV promoters has demonstrated some common features and 
some class-specific ones. A TAT A box or its variant is generally 
(but not always) seen around 30 bases upstream from specific 
mRNA cap sites. In early (beta) promoters, a string of approx­
imately 15 bases that are very AC-rich in no particular order is 
seen around 100 bases upstream from the cap site. Late pro­
moters do not show this feature, but often have an AT-rich 
region at about this position. These features have been tabu­
lated [3]. 
Translation frames. The mRNAs we have currently identi­
fied have leaders of around 150 bases between the cap site and 
the probable initiation codon. Specific sequences in such leaders 
can diverge quite widely. This conclusion is based on compari­
son of the sequence for the 1.2-kb early mRNA encoding the 
38,000 dalton protein mapping between 0.59-0.60 and the cor­
responding HSV-2 sequence ( [16) and Galloway, personal com­
munication). 
Translation initiation codons are often the canonical Pu-­
ATGG. The high G+C content of HSV DNA is reflected in 
codon use frequency, but such frequency is notably assymmetric 
(reviewed in [3)). High proline contents are common in the 
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FIG 5. Specific competition of double-strand HSV -1 BamHI frag­
ment F' (0.268-0.272) binding to protein transfer (Western) blots of 
high-salt extracts of HSV -infected HeLa cell nuclei. Cells were isolated 
at 8 h after infection and nuclear proteins were extracted with 1.7 M 
salt. These were fractionated on SDS-polyacrylamide gels by electro­
phoresis and transferred to nitrocellulose. Blots were incubated with 
32P-labeled (nick-translated) double-stranded BamHI fragment F' 
DNA. This labeled DNA was mixed with a large excess of unlabeled 
competing DNA as indicated. 
predicted amino acid contents of HSV proteins, but they can 
vary widely. The very high proline content predicted for HSV-
1 gC may account for the discrepancy between its calculated 
residue molecular weight and that actually observed. 
Termination signals are generally repeated several times in 
phase downstream from the first seen in a given reading frame. 
Trailer sequences can vary from a length of approximately 10 
bases to many kilobases between termination and polyadeny­
lation signals. 
Splices. As noted earlier, splicing is rare in HSV -1. In the 
case of the gC transcription unit, several splice signals appear 
to function at low frequency [7). We have not fully character­
ized the splice donor sequence, but it is very short (ca. 25-50 
bases). Canonical splice acceptor signals are seen at positions 
corresponding to the located acceptors determined by high­
resolution 81 mapping. We have not determined any biological 
function for the spliced mRNA species we have seen. Several 
alternate reading frames for translation could be utilized in one 
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or another of them, and one species could give rise to a protein 
sharing the C-terminal sequence of the gC protein. None of 
these proteins has been rigorously identified either by in vitro 
translation or in the infected cell. 
Partially overlapping mRNAs. Several mRNAs sharing the 
same polyadenylation site is a common feature of the HSV 
transcription map. These overlapping mRNAs appear to have 
independent 5' ends under their own promoter control. Such 
promoter regions can lie within a translational reading frame 
of an upstream mRNA. 
It is not at all clear whether the partial overlapping of 
mRNAs encoding distinct proteins is a reflection of closely 
related function. In a number of cases, we have found that 
there is no obvious immunologic cross-reactivity between such 
proteins [7,13], yet the situation with the two identified ribo­
nucleotide reductase mRNAs reviewed [3] suggests that the 
140,000 and 38,000 dalton proteins encoded by distinct trans­
lational reading frames do share an epitope. Further, we have 
found that the 1 .9-kb mRNA underlying the 3' end of the 2.3-
kb alkaline exonuclease mRNA may well share that mRNA's 
translational reading frame [8]. Thus further data are needed 
to make generalizations. 
Polyadenylation sites. The polyadenylation signal for HSV 
mRNAs appears to be the canonical AATAAA(A). Often, tran­
script groups or "families" encoded by both strands of the viral 
DNA have their polyadenylation signals close together. We 
have determined the nucleotide sequence between such juxta­
posed polyadenylation signals in the region around 0.60 for 
both HSV -1 and HSV -2 (Draper, Frink, Devi, Galloway, Swain, 
and Wagner, submitted). It is seen that the region in both virus 
types is characterized by a high A+T composition. However, 
there is no evidence of any sequence conservation between the 
two types. In fact, HSV -2 has an extra 70 or so bases in this 
region when compared with HSV -1. However, as soon as the 
analogous translational reading frames are encountered, a good 
deal of homology is noted. 
DISCUSSION 
The data briefly described in this review of work carried out 
in my laboratory indicate that we have a good understanding 
of the physical properties of individual HSV transcription 
units. Hopefully, such knowledge will be of great value in 
gaining a full description of the molecular biology of the her­
pesviruses in general. Deciphering the molecular processes re­
sponsible for the complex biology of these viruses will not be a 
trivial task. However, gene packaging of the viruses appears to 
be readily interpretable. Further, data presented allow the 
inference that temporal regulation of the expression of specific 
viral functions requires trans action of viral regulatory func­
tions on defined regions of the viral genome. The large number 
of such regulatory sequences and the fact that they can be 
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located readily suggest potentially fruitful approaches for in­
vestigation of the actual molecular processes involved in this 
control. 
I thank R. Costa, G. Devi, K. Draper, R. Frink, L. Hall, and M. Rice 
for their participation in my efforts. I also thank W. Steinhart, of 
Bowdoin College, for allowing me to quote from unpublished results of 
work done during his sabbatical in this laboratory. 
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